Pediatrics Medical News about Invasive Candida Infections

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Micafungin: A Review of its Use in the Prophylaxis and Treatment of Invasive Candida Infections in Pediatric Patients
Pediatric Drugs, 07/27/09

Carter NJ et al. – Intravenous micafungin is an echinocandin indicated in Japan and the EU for the treatment of pediatric patients with invasive candidiasis and as prophylaxis against Candida infection in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation. In the EU, micafungin is also indicated in pediatric patients who are expected to have neutropenia for >=10 days.

<< Previous
Etiology, Diagnosis, and Pharmacologic Treatment of Pediatric...

Next >>
Pediatric Palliative Care: Use of Opioids for the Management of...

Characterization of Candida parapsilosis infection of an in vitro reconstituted human oral epithelium
European Journal of Oral Sciences, 11/16/09 Relevance Score: 80%

Candida and the paediatric lung
Paediatric Respiratory Reviews, 11/06/09 Relevance Score: 80%

Candidiasis: New agents for invasive infections
The Clinical Advisor, 10/06/09 Relevance Score: 79%

Antifungal susceptibility of 205 Candida sp. primarily isolated during invasive candidiasis. Comparison of the Vitek2 system with CLSI broth microdilution and Etest methods
Journal of Clinical Microbiology, 11/13/09 Relevance Score: 78%

The vacuole-targeting fungicidal activity of amphotericin B against the pathogenic fungus Candida albicans and its enhancement by allicin
The Journal of Antibiotics, 11/05/09 Relevance Score: 78%